Comparison of Analgesic Efficacy of Wound Infiltration with Bupivacaine versus Bupivacaine and Tramadol for Postoperative Pain Relief in Lower Segment Caesarean Section under Spinal Anaesthesia
Background: Effective postoperative pain management after lower segment caesarean section (LSCS) is essential for early maternal recovery, initiation of breastfeeding, and improved maternal–infant bonding. Inadequate analgesia may lead to delayed ambulation, prolonged hospital stay, and increased postoperative complications. Wound infiltration with local anesthetics is a simple and effective technique for providing postoperative analgesia following caesarean section. Bupivacaine is widely used for wound infiltration because of its long duration of action and favourable safety profile. Tramadol, an opioid analgesic with additional monoaminergic activity, has been studied as an adjuvant to local anesthetics to enhance postoperative analgesia. The addition of tramadol to bupivacaine may prolong analgesic duration and improve postoperative pain control. Aim: To compare the analgesic efficacy of wound infiltration with bupivacaine alone versus bupivacaine combined with tramadol for postoperative pain relief in patients undergoing lower segment caesarean section under spinal anaesthesia. Materials and Methods: This prospective, randomized, double-blinded comparative clinical study was conducted in the Department of Anaesthesiology at Sri Siddhartha Medical College and Research Institute, Tumkur, Karnataka, India, over a 24-month period. A total of 60 parturients undergoing elective LSCS under spinal anaesthesia were included in the study. Patients were randomly allocated into two groups (n = 30 each): Group B (Bupivacaine group) received wound infiltration with 0.25% bupivacaine alone, whereas Group BT (Bupivacaine + Tramadol group) received 0.25% bupivacaine combined with tramadol at a dose of 2 mg/kg. Postoperative pain was assessed using the Visual Analogue Scale (VAS), and parameters such as duration of analgesia, time to first rescue analgesic, total analgesic consumption, and adverse effects were recorded. Results: Patients receiving bupivacaine combined with tramadol demonstrated significantly prolonged postoperative analgesia, lower VAS pain scores, and delayed requirement for rescue analgesia compared with patients receiving bupivacaine alone. The combination group also showed reduced total analgesic consumption in the postoperative period without significant increase in adverse effects. Conclusion: Wound infiltration with bupivacaine combined with tramadol provides superior postoperative analgesia compared with bupivacaine alone in patients undergoing LSCS under spinal anaesthesia. The addition of tramadol enhances the duration and quality of postoperative pain relief without significant complications.
Read more